6533b7dcfe1ef96bd1271f52

RESEARCH PRODUCT

Covid-19 in Philadelphia-negative myeloproliferative neoplasms: a GIMEMA survey on incidence, clinical management and vaccine

M. BrecciaA. PiciocchiM. MessinaS. SodduV. De StefanoM. BelliniA. IurloB. MartinoS. SiragusaF. AlbanoB. MoraP. FaziM. VignettiP. GuglielmelliF. Palandri

subject

VaccinesCancer ResearchMyeloproliferative DisordersOncologyCOVID19IncidenceNeoplasmsMPNsCOVID-19HumansPhiladelphia ChromosomeHematologyhttps://doi.org/10.1038/s41375-022-01675-1